Showing results (631-640 of 2,182) with videos related to

Sort By:
Pageof 219
The Journal of Gene Medicine|December 9, 2003
In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult ratsYun Zhang, Ruben J Boado, William M Pardridge
The Journal of Gene Medicine|December 9, 2003
Increased in vitro and in vivo transgene expression levels mediated through cis-acting elementsJens Johansen, Jens Tornøe, Arne Møller, et al.
The Journal of Gene Medicine|February 16, 2013
Genetic blockade of insulin-like growth factor-1 receptor via recombinant adenovirus in lung cancer can be enhanced by the histone deacetylase inhibitor, vorinostatMi-Young Park, Dal Rae Kim, Eun Young Eo, et al.
The Journal of Gene Medicine|January 11, 2013
U6 promoter-enhanced GlnUAG suppressor tRNA has higher suppression efficacy and can be stably expressed in 293 cellsRamesh Koukuntla, William J Ramsey, Won-Bin Young, et al.
The Journal of Gene Medicine|December 11, 2012
Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cellsJosephine M Janssen, Jin Liu, Jaroslav Skokan, et al.
The Journal of Gene Medicine|January 16, 2013
High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectorsManij Patel, Angela M Giddings, John Sechelski, et al.
The Journal of Gene Medicine|January 17, 2013
Patient monitoring and follow-up in lentiviral clinical trialsGerard J McGarrity, Gloria Hoyah, April Winemiller, et al.
The Journal of Gene Medicine|March 23, 2012
Cationic microparticle [poly(D,L-lactide-co-glycolide)]-coated DNA vaccination induces a long-term immune response against foot and mouth disease in guinea pigsKotla S Reddy, Brabhi R Rashmi, Hosur J Dechamma, et al.
The Journal of Gene Medicine|March 23, 2012
Adeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivoMaria Pihlmann, Anne Louise Askou, Lars Aagaard, et al.
The Journal of Gene Medicine|March 23, 2012
Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathwayYuying Wei, Yuanjie Sun, Chaojun Song, et al.
Pageof 219